This article was originally published in Start Up
Traditional home treatments for chronic pain, such as topical creams, hot pads, cold packs, prescription drugs and transcutaneous nerve stimulation are plentiful, yet only half of America's chronic pain sufferers report their pain as under control. Consumers may soon have a better option for treating their pain: a wearable ultrasound system that is portable, affordable and easy to use. TheraSonX from ZetrOZ LLC uses low-intensity ultrasound delivered through an iPod-sized applicator to provide continuous therapy for up to six hours while patients are engaged in normal activities.
You may also be interested in...
A preview of the emerging health ncompanies profiled in the current issue of Start-Up. This month's profile group, "Noninvasive Body Contouring Begins To Take Shape," features profiles of EndyMed, Slender Medical and Zeltiq. Plus these Start-Ups Across Health Care: Auxogyn, Mucosis, NuVue Therapeutics, Taiga Biotechnologies and ZetrOZ.
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.